Tackling immunosenescence to improve COVID-19 outcomes and vaccine response in older adults

• Lynne S Cox,
• Ilaria Bellantuono,
• Janet M Lord,
• Elizabeth Sapey,
• Joan B Mannick,
• Linda Partridge,
• Adam L Gordon,
• Claire J Steves,
• Miles D Witham

Affiliations

Lynne S Cox

Department of Biochemistry, University of Oxford, Oxford OX1 3QU, UK

Ilaria Bellantuono

Healthy Lifespan Institute, Department of Oncology and Metabolism, The University of Sheffield, Sheffield, UK

Janet M Lord

MRC-Versus Arthritis Centre for Musculoskeletal Ageing Research, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK

Elizabeth Sapey

PIONEER HDR-UK Hub in Acute Care, University of Birmingham, Birmingham, UK; NIHR/Wellcome Trust Birmingham Clinical Research Facility and Acute and Respiratory Medicine, Queen Elizabeth Hospital, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK

Joan B Mannick

resTORbio, Boston, MA, USA

Linda Partridge

Max Planck Institute for Biology of Ageing, Cologne, Germany; Institute of Healthy Ageing and GEE, UCL, London, UK

Adam L Gordon

University of Nottingham, Nottingham, UK; NIHR Applied Research Collaboration East Midlands, Nottingham, UK; University Hospitals of Derby and Burton NHS Foundation Trust, Derby, UK

Claire J Steves

St Guy's and St Thomas’ Hospital, London, UK; Department of Twin Research and Genetic Epidemiology, King's College London, London, UK

Miles D Witham

AGE Research Group, NIHR Newcastle Biomedical Research Centre, Newcastle University, Newcastle upon Tyne Hospitals NHS Foundation Trust